摘要
目的探讨美托洛尔联合胺碘酮治疗心律失常的临床效果。方法选取我院2015年9月至2016年3月收治的72例心律失常患者为研究对象,采用随机数字表法分为对照组和试验组,每组36例。对照组患者治疗时予以胺碘酮,试验组患者治疗时予以美托洛尔联合胺碘酮。比较两组患者的临床治疗效果。结果治疗后,试验组室性心动过速与室性早搏的治疗总有效率为91.67%,明显高于对照组的66.67%(P<0.05)。治疗后,试验组心功能与心绞痛的治疗总有效率为88.89%,明显高于对照组的63.89%(P<0.05)。结论对心律失常的患者采用美托洛尔联合胺碘酮治疗,临床效果显著,安全性高,值得临床推广应用。
Objective To investigate the curative effect of metoprolol combined with amiodarone in the treatment of arrhythmia. Methods Seventy-two arrhythmia patients admitted in our hospital from September 2015 to March 2016 were selected and divided into control group and experimental group with random table method, with 36 cases in each group. The control group was given amiodarone, and the experimental group was treated with metoprolol combined with amio- darone. The clinical effects of the two groups were compared. Results After treatment, the total effective rate of ventrieu- lar tachyeardia and premature ventricular contraction treatment in the experimental group was 91.67%, which was higher than 66.67% in the control group (P〈0.05). After treatment, the total effective rate of heart function and angina peetoris treatment in the experimental group was 88.89%, which was higher than 63.89% in the control group (P〈0.05). Conclusion Metoprolol combined with amiodarone in the treatment of arrhythmia has significant curative effect. It has high safety, which is worthy of clinical application and promotion.
出处
《临床医学研究与实践》
2017年第27期36-37,共2页
Clinical Research and Practice